Frontiers 22 Bergamo Session 8: When and How to Inhibit C3 in Complement-mediated Rare Nephropathies

Recorded On: 07/11/2022


Back to Package

  1. Manipulating the Early Steps of Complement Cascade: Emerging Drugs, Potential Risks, and Benefits 
  2. Lessons from Studies in Mouse Models of C3G 
  3. Targeting C3, CFD, or CFB in C3G, Preliminary Results of Clinical Trials in Patients with C3G/IC-MPGN 
  4. Oral Presentation from Abstract Selection
  5. Q&A Discussion 

Joshua Thurman

USA

Ariela Benigni

Italy

Erica Daina

Italy

Key:

Complete
Failed
Available
Locked
Session 8: When and How to Inhibit C3 in Complement-mediated Rare Nephropathies
Open to view video.
Open to view video.